Transcatheter Heart Valves Market to Reach Valuation of US$ 5616.5 Mn and expanding at a CAGR of 15.8% by 2027

The global Transcatheter Heart Valves market was valued at US$ 1979 million in 2020 and is expected to reach US$ 5616.5 million by the end of 2027, growing at a CAGR of 15.8% during 2021-2027.

The sales volume of transcatheter heart valves is increasing across several healthcare centers due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement.

Increasing mortality due to chronic and end-stage cardiovascular diseases in the elderly population is a key concern for the healthcare providers across the world. As per the American Heart Association estimates in 2017, nearly 19.1 million deaths occur each year due to various cardiovascular diseases. In the U.S., heart disease is a leading cause of death, accounting for approximately 375,000 deaths per year.

Global Transcatheter Heart Valves Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Transcatheter Heart Valves Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.

Key Companies profiled in this report are Boston Scientific Corporation, Abbott, Edwards Lifesciences Corporation, Colibri Heart Valve, On-X Life Technologies, Jenavalve Technology and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.

Find more details at:

Segment by Type

  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve

Segment by Application

  • Hospitals
  • Clinics

Table of Content:

1 Transcatheter Heart Valves Market Overview

2 Transcatheter Heart Valves Market Competition by Manufacturers

3 Transcatheter Heart Valves Retrospective Market Scenario by Region

4 Global Transcatheter Heart Valves Historic Market Analysis by Type

5 Global Transcatheter Heart Valves Historic Market Analysis by Application

6 Key Companies Profiled

7 Transcatheter Heart Valves Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Transcatheter Heart Valves Market Dynamics

10 Global Transcatheter Heart Valves Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Media Contact

Company Name: The Market Reports

Contact Person: Shirish Gupta


Phone: +1-631-407-1315